Reporterlink has released market research on the global orthopedic instrumentation industry including estimates and forecasts for 2009 to 2017.

Regentis Biomaterials, a company focused on developing proprietary hydrogels for tissue regeneration, has raised $10 million in its latest round of funding from new investors Royal DSM through its venturing subsidiary, Crossroad Fund, Medica Venture Partners, SCPVitalife and Technion Investment Opportunities Fund.

The United States biomaterials market shows significant potential for growth in the future, according to a report from iData research.

BioMimetic Therapeutics, a Franklin, Tenn.-based medical device company, reported a net loss of $6.1 million during the first quarter of 2012.

San Francisco-based SpineGuard has expanded its United States sales and established four areas to support demand from independent distributors and market its PediGuard family of products.

The drastic increase in spinal fusions performed by surgeons in the United States has been attributed to several factors, including economic incentives for providers and relationships with device companies. However, there are several other, more subtle, factors that have contributed to the rise of spinal fusions that surgeons are keenly aware of, even if they aren't always mentioned in healthcare legislation and policy debates.

Wright Medical Group reported a 6 percent decrease in first quarter net sales to $126.7 million, driven by previously announced distributor transitions and challenges associated with the company's compliance processes.

Exactech reported net income of $3.3 million during the first quarter of 2012, a slight increase over the same period in 2011.

Zimmer reported $1.4 billion in first quarter net sales, a 2.2 percent increase over the same period last year.

Orthofix's first quarter net sales were reported at $143.1 million, a 3 percent growth over the same period last year, with spine products net sales up 3 percent to $75 million and orthopedics up 1 percent to $41 million.